Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : DBVT save search
Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
Published: 2024-04-04 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -4.84%
H: 15.76%
C: 14.1%
company total
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
Published: 2024-03-08 (Crawled : 14:30) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -0.73%
H: 5.96%
C: 4.63%
report universal
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-07 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -0.73%
H: 5.96%
C: 4.63%
business year update financial results
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
Published: 2024-03-04 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -3.16%
H: 4.22%
C: 2.4%
report business year update financial results
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
Published: 2024-02-20 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -1.99%
H: 7.29%
C: 5.21%
congress
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
Published: 2024-01-16 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 1.69%
H: 0.0%
C: -2.95%
report contract
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023
Published: 2023-12-04 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 4.29%
H: 4.41%
C: 1.85%
company total
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
Published: 2023-11-09 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 4.92%
H: 2.06%
C: -2.05%
peanut ongoing extension trial results
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
Published: 2023-11-06 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -2.0%
H: 2.04%
C: 0.0%
company total
DBV Technologies to Present New Data at ACAAI 2023
Published: 2023-11-02 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 4.0%
H: 0.0%
C: -0.96%
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
Published: 2023-10-31 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 4.95%
H: 1.42%
C: -3.77%
fda comfort financial results
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
Published: 2023-10-27 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
| Email alert
Add to watchlist
report business update financial results
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
Published: 2023-10-16 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 0.85%
H: 1.69%
C: -1.69%
financial
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
Published: 2023-10-05 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 0.81%
H: 1.6%
C: -4.0%
company total
DBV Technologies to Participate in Upcoming Investor Conference
Published: 2023-09-05 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -2.86%
H: 3.53%
C: -2.94%
conference
DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
Published: 2023-07-31 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 12.16%
H: 0.0%
C: -3.01%
fda peanut financial results
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
Published: 2023-07-25 (Crawled : 20:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: -3.61%
H: 2.5%
C: 0.63%
report update financial results
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
Published: 2023-07-19 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 0.59%
H: 0.58%
C: -1.75%
total
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
Published: 2023-07-10 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
|
| O: 0.56%
H: 1.12%
C: 0.56%
report contract
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023
Published: 2023-06-16 (Crawled : 21:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K
|
Health Technology
| Email alert
Add to watchlist
total
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.